尖峰集团：子公司艾司奥美拉唑镁肠溶干混悬剂通过药品GMP符合性检查
尖峰集团2月7日公告，近日，公司的全资子公司尖峰药业从浙江省药品监督管理局网站获悉药品GMP符合性检查结果公告。主要生产品种为艾司奥美拉唑镁肠溶干混悬剂，主要用于反流性食管炎的治疗。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Related News
